Invitro testing of Advanced JAX(TM) Bone Void Filler System: species differences in the response of bone marrow stromal cells to b tri-calcium phosphate and carboxymethylcellulose gel

The Advanced JAX(TM) Bone Void Filler System (AJBVFS) is a novel bone graft material manufactured by Smith and Nephew Orthopaedics Ltd. and comprises b tri-calcium phosphate granules with carboxymethylcellulose (CMC) gel as a handling agent. This study investigated the potential, invitro, of the AJB...

Full description

Saved in:
Bibliographic Details
Published inJournal of materials science. Materials in medicine Vol. 18; no. 12; pp. 2283 - 2290
Main Authors Clarke, SA, Hoskins, N L, Jordan, G R, Henderson, SA, Marsh, DR
Format Journal Article
LanguageEnglish
Published 01.12.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The Advanced JAX(TM) Bone Void Filler System (AJBVFS) is a novel bone graft material manufactured by Smith and Nephew Orthopaedics Ltd. and comprises b tri-calcium phosphate granules with carboxymethylcellulose (CMC) gel as a handling agent. This study investigated the potential, invitro, of the AJBVFS to function as a delivery system for cell therapy to enhance healing of bone defects. The attachment of rabbit bone marrow stromal cells (rbBMSCs), human BMSCs (hBMSCs) and human bone-derived cells (hBDCs) to JAX(TM) granules and the effect of CMC gel on cell proliferation and differentiation were investigated. There were slight species differences in the number and morphology of cells attached on the JAX(TM) granules with less rbBMSC attachment than human. All cells tolerated the presence of CMC gel and a reduction in cell number was only seen after longer exposure to higher gel concentrations. Low concentrations of CMC gel enhanced proliferation, alkaline phosphatase (ALP) expression and ALP activity in human cells but had no effect on rbBMSC. This study suggests that AJBVFS is an appropriate scaffold for the delivery of osteogenic cells and the addition of CMC gel as a handling agent promotes osteogenic proliferation and differentiation and is therefore likely to encourage bone healing.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0957-4530
1573-4838
DOI:10.1007/s10856-007-3099-1